The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk.
The clinical evaluation of osteoporosis in individual patients involves confirmation of the diagnosis, the investigation of secondary causes of osteoporosis and the evaluation of subsequent fracture risk. Optimum clinical assessment involves bone mineral densitometry with the treatment thresholds modified by clinical risk factors for individual patients. Bone turnover markers and clinical risk factors can be used to identify patients at risk of osteoporotic fracture and those who have secondary osteoporosis. Risk assessment should involve the evaluation of absolute rather than relative risk. Further work is required to improve the integration of clinical risk factors, bone turnover markers and bone densitometry into appropriate models to enable the assessment of the absolute risk of fracture for individual patients.
Clowes
J A
JA
University of Sheffield, Division of Clinical Sciences (NGHT), Clinical Sciences Centre, Northern General Hospital, Herries Road, Sheffield, S5 7AU, England.
Eastell
R
R
D015415:Biomarkers; D016723:Bone Remodeling / Q000502:physiology*; D050723:Fractures, Bone / Q000209:etiology*; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology*; D011379:Prognosis; D012307:Risk Factors
D015415:Biomarkers